Company Profile: Better Medicine
Overview
Better Medicine is an AI-driven HealthTech company, headquartered in Estonia, that specializes in cancer diagnostics. The company employs artificial intelligence to enhance radiology workflows, focusing on a holistic, multi-organ approach. Better Medicine provides seamless integration into existing medical systems for precise cancer detection and progress monitoring.
Vision and Mission
Mission: The mission of Better Medicine is to revolutionize cancer diagnostics by easing the burden on radiologists and improving patient outcomes globally. Utilizing AI-driven tools, the company seeks to detect lesions, measure tumor progression, and monitor treatment responses, thereby increasing diagnostic efficiency and reducing manual tasks.
Key Executives
- Priit Salumaa - CEO & Founder: An influential figure in health technology, Salumaa co-founded Better Medicine during the COVID-19 pandemic. His leadership is focused on digital transformation in healthcare, particularly in cancer diagnostics.
- Dmytro Fishman - Chief Science Officer (CSO): A senior researcher and lecturer in AI at the University of Tartu, Fishman co-founded Better Medicine to advance AI models that enhance cancer detection and patient care.
- Bohdan Petryshak - Chief AI Engineer: With expertise in medical imaging startups, Petryshak leads Better Medicine's AI engineering team, developing advanced diagnostic tools.
- Helena Ije - Chief Operating Officer (COO): With strengths in regulatory processes and operations, Ije is pivotal in guiding the company's logistics and strategic direction.
- Vitalii Lakusta - Former CTO: A foundational figure in establishing the technology framework of Better Medicine, Lakusta played a crucial role in early product development.
Recent Achievements
- Funding: Awarded a €2.5M grant from the European Innovation Council’s Accelerator to enhance the development of AI solutions in cancer diagnostics.
- Collaborations and Validation: Successfully partnered with Tartu University Hospital and Pärnu Hospital for clinical validation. Expanded its European presence by establishing a digital office in Leeds, England.
- Certifications: Attained ISO 13485 certification, reinforcing quality and compliance in medical device manufacturing standards.
Products and Solutions
Better Medicine offers key products that incorporate AI to transform the landscape of cancer diagnostics:
- BMVision, BMViewer, BMGateway, and iMeasure: These solutions automate lesion measurements, diagnostics, and reporting, enabling radiologists to shift focus from routine tasks to patient care.
- AI Diagnostic Models: Advanced tools designed to automatically detect primary tumors and metastases, supporting healthcare professionals in making informed clinical decisions.
Industry Impact
Better Medicine is pushing the boundaries in HealthTech by developing innovative AI applications for healthcare. The company's commitment to research and innovation aims to alleviate the global challenges in cancer imaging, potentially saving 13 million hours annually for radiologists worldwide.
Future Outlook
With its pioneering technology and effective leadership, Better Medicine plans to broaden its market presence and influence through additional partnerships and clinical trials. The company's trajectory, fueled by continued support from grants and collaborations, points toward significant health care improvements and growth in AI diagnostics.
Online Presence
- Website: [bettermedicine.ai](https://bettermedicine.ai/)
Competitor Profile
Overview
As a competitor in the AI-driven diagnostic space, Better Medicine stands out for its comprehensive multi-organ approach and focus on improving radiologist efficiency in cancer detection. Despite not being among the top global AI healthcare companies, it competes with several notable entities.
Competitors
Key competitors of Better Medicine in the healthcare AI industry include:
- Lunit and Median: Well-known players in the medical AI space.
- Arterys: Offers internet-based platforms for enhanced radiology accuracy and efficiency with several FDA-cleared AI products.
- Butterfly Network: Specializes in cost-effective AI-assisted ultrasound technologies, delivering clear diagnostic insights at the point of care.
- Caption Health: Recently acquired by GE HealthCare, it focuses on AI-driven solutions in cardiovascular imaging to improve early disease detection.
- Cleerly: Uses AI to enhance cardiac care by providing software that improves understanding and treatment of coronary artery disease.
- CloudMedx: Provides cognitive computing platforms, emphasizing AI solutions for comprehensive health data management.
Strategic Opportunities
To excel, Better Medicine must continuously refine its AI integration for comprehensive radiology diagnostics. Proactively engaging in partnerships and expanding into broader oncological diagnostics can present considerable growth opportunities as the AI healthcare market evolves.
